Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Tables)

v3.21.2
Shareholders' Equity (Tables)
6 Months Ended
Jul. 31, 2021
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of warrants outstanding [Table Text Block]

    

Warrants

    

Warrants

    

Exercise Price

    

Grant Date

Outstanding

Exercisable

(Per Share)

Expiration Date

September 19, 2016

 

297,619

 

297,619

$

29.00

 

September 19, 2021

November 10, 2016

 

33,386

 

33,386

$

30.00

 

November 10, 2021

January 23, 2017

 

48,930

 

48,930

$

17.60

 

January 23, 2022

March 16, 2017

 

5,000

 

5,000

$

19.20

 

March 16, 2022

May 2, 2019

 

349,998

 

349,998

$

15.00

 

May 2, 2024

April 17, 2020

367,197

367,197

$

2.66

April 14, 2025

May 22, 2020

122,398

122,398

$

2.66

April 14, 2025

June 8, 2020

122,399

122,399

$

2.66

April 14, 2025

June 12, 2020

122,398

122,398

$

2.66

April 14, 2025

July 11, 2020

244,798

244,798

$

2.66

April 14, 2025

Schedule of stock options valuation assumptions [Table Text Block]

The fair value of each time-based vesting option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions noted in the following table. Expected volatilities are based on the historical volatility of the Company’s stock. Expected term is calculated using the simplified method taking into consideration the option’s contractual life and vesting terms.

The Company uses the simplified method in estimating its expected option term because it believes that historical exercise data cannot be accurately relied upon at this time to provide a reasonable basis for estimating an expected term due to the extreme volatility of its stock price and the resulting unpredictability of its stock option exercises. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. Expected dividend yields were not used in the fair value computations as the Company has never declared or paid dividends on its common stock and currently intends to retain earnings for use in operations.

    

Fiscal 2021

    

Expected volatility:

 

89%

 

Expected term (in years):

 

6 years

 

Risk-free interest rate:

 

1.05%

 

Schedule of stock option activity [Table Text Block]

A summary of the status of the Company’s stock option activity as of July 31, 2021 and changes during the six months then ended is as follows:

2020

Weighted

Weighted

Weighted

Equity

Average 

Average 

Average 

Incentive

Exercise 

2011

Exercise 

2004

Exercise 

Plan

Price

Plan

Price

Plan

Price

Balance outstanding, January 30, 2021

$

 

34,000

$

12.87

 

3,000

$

53.49

Granted

68,000

$

9.08

 

$

 

$

Exercised

$

 

$

 

$

Forfeited or canceled

$

 

$

 

$

Balance outstanding, July 31, 2021

68,000

$

9.08

 

34,000

$

12.87

 

3,000

$

53.49

Options exercisable at July 31, 2021

$

 

30,000

$

13.67

 

3,000

$

53.49

Schedule of stock options outstanding, vested and expected to vest [Table Text Block]

The following table summarizes information regarding stock options outstanding as of July 31, 2021:

Options Outstanding

Options Vested or Expected to Vest

    

    

    

Weighted

    

    

    

    

Weighted

    

Average 

Average 

Weighted

Remaining 

Weighted

Remaining 

Average 

Contractual 

Aggregate

Average 

Contractual 

Aggregate

Number of

Exercise 

Life 

Intrinsic 

Number of

Exercise 

Life 

Intrinsic 

Option Type

Shares

Price

 

(Years)

Value

Shares

Price

 

(Years)

Value

2011 Incentive:

68,000

$

9.08

9.6

$

42,000

8.72

9.6

$

2011 Incentive:

 

34,000

$

12.87

 

5.6

$

16,000

 

33,000

$

13.01

 

5.5

$

15,000

2004 Incentive:

 

3,000

$

53.49

 

2.6

$

 

3,000

$

53.49

 

2.6

$

Valuation assumptions of May 2, 2019 market-based restricted stock unit [Table Text Block]

Grant date fair values and derived service periods for each tranche were determined using a Monte Carlo valuation model based on assumptions, which included a weighted average risk-free interest rate of 2.5%, a weighted average expected life of 2.9 years and an implied volatility of 80% and were as follows for each tranche:

    

Fair Value

    

Derived Service

(Per Share)

Period

Tranche 1 (one year)

$

3.66

 

1.00 Year

Tranche 2 ($20.00/share)

$

3.19

 

3.27 Years

Tranche 3 ($40.00/share)

$

2.85

 

4.53 Years

Schedule of restricted stock unit activity [Table Text Block]

A summary of the status of the Company’s non-vested restricted stock unit activity as of July 31, 2021 and changes during the six-month period then ended is as follows:

Restricted Stock Units

Market-Based Units

Time-Based Units

    

Performance-Based Units

    

Total

    

    

Weighted

    

    

Weighted

    

Weighted

    

Weighted

Average

Average 

Average

Average 

Grant Date

Grant Date 

Grant Date

Grant Date 

Shares

    

Fair Value

    

Shares

Fair Value

    

Shares

    

Fair Value

    

Shares

Fair Value

Non-vested outstanding, January 30, 2021

 

60,000

$

3.52

 

736,000

$

4.03

 

146,000

$

1.69

942,000

$

3.64

Granted

 

77,000

$

8.72

 

812,000

$

9.05

 

$

889,000

$

9.02

Vested

 

$

 

(334,000)

$

5.82

 

$

(334,000)

$

5.82

Forfeited

 

$

 

(171,000)

$

9.78

 

$

(171,000)

$

9.78

Non-vested outstanding, July 31, 2021

 

137,000

$

5.46

 

1,043,000

$

5.82

 

146,000

$

1.69

1,326,000

$

5.33